Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
CDLX

CDLX - Cardlytics Inc Stock Price, Fair Value and News

8.90USD-0.03 (-0.34%)Market Closed

Market Summary

CDLX
USD8.90-0.03
Market Closed
-0.34%

CDLX Stock Price

View Fullscreen

CDLX RSI Chart

CDLX Valuation

Market Cap

433.7M

Price/Earnings (Trailing)

-2.51

Price/Sales (Trailing)

1.39

EV/EBITDA

-3.77

Price/Free Cashflow

-49.87

CDLX Price/Sales (Trailing)

CDLX Profitability

EBT Margin

-55.23%

Return on Equity

-86.67%

Return on Assets

-30.33%

Free Cashflow Yield

-2.01%

CDLX Fundamentals

CDLX Revenue

Revenue (TTM)

312.5M

Rev. Growth (Yr)

5.09%

Rev. Growth (Qtr)

-24.18%

CDLX Earnings

Earnings (TTM)

-172.6M

Earnings Growth (Yr)

-278.39%

Earnings Growth (Qtr)

75.93%

Breaking Down CDLX Revenue

Last 7 days

10.0%

Last 30 days

7.9%

Last 90 days

-25.5%

Trailing 12 Months

-10.3%

How does CDLX drawdown profile look like?

CDLX Financial Health

Current Ratio

2.13

Debt/Equity

1.14

Debt/Cashflow

-0.03

CDLX Investor Care

Shares Dilution (1Y)

43.87%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024312.5M000
2023294.9M296.2M302.5M309.2M
2022281.8M298.4M306.1M298.5M
2021194.6M225.2M244.1M267.1M
2020220.0M199.4M189.1M186.9M
2019154.0M167.1M189.0M210.4M
2018136.2M139.0M142.1M150.7M
2017117.2M121.6M126.0M130.4M
2016000112.8M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Cardlytics Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jul 02, 2024
lynton nicholas hollmeyer
sold
-47,368
7.953
-5,956
chief legal & privacy officer
Jul 02, 2024
desieno alexis
sold
-59,257
7.953
-7,451
chief financial officer
Jul 02, 2024
gupta amit
sold
-59,703
7.953
-7,507
chief operating officer
Jul 01, 2024
lynton nicholas hollmeyer
acquired
-
-
12,788
chief legal & privacy officer
Jul 01, 2024
desieno alexis
acquired
-
-
14,349
chief financial officer
Jul 01, 2024
gupta amit
acquired
-
-
14,349
chief operating officer
Jun 28, 2024
sosin clifford
sold
-
-
-45,126
-
Jun 04, 2024
temsamani karim saad
sold
-373,282
8.655
-43,129
chief executive officer
Jun 01, 2024
temsamani karim saad
acquired
-
-
84,079
chief executive officer
May 23, 2024
lapic s aimee
acquired
-
-
28,547
-

1–10 of 50

Which funds bought or sold CDLX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jul 16, 2024
SHIKIAR ASSET MANAGEMENT INC
reduced
-28.5
-346,000
236,000
0.06%
Jul 16, 2024
GPS Wealth Strategies Group, LLC
unchanged
-
-1,884
2,463
-%
Jul 12, 2024
Register Financial Advisors LLC
unchanged
-
-628
821
-%
Jul 12, 2024
SG Americas Securities, LLC
sold off
-100
-145,000
-
-%
Jul 10, 2024
CWM, LLC
added
100
-
-
-%
Jul 10, 2024
CVA Family Office, LLC
unchanged
-
-3,140
4,105
-%
Jul 02, 2024
GAMMA Investing LLC
added
181
3,321
8,900
-%
Jul 01, 2024
Legal & General Group Plc
unchanged
-
16,410
45,035
-%
Jun 21, 2024
Abich Financial Wealth Management LLC
sold off
-100
-1,225
-
-%
May 21, 2024
LRI Investments, LLC
new
-
1,449
1,449
-%

1–10 of 38

Are Funds Buying or Selling CDLX?

Are funds buying CDLX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CDLX
No. of Funds

Unveiling Cardlytics Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jul 02, 2024
cas investment partners, llc
13.2%
6,419,733
SC 13D/A
Mar 29, 2024
cas investment partners, llc
14.4%
6,373,676
SC 13D/A
Mar 18, 2024
cas investment partners, llc
13.7%
6,023,676
SC 13D/A
Feb 14, 2024
683 capital management, llc
4.6%
1,758,462
SC 13G/A
Feb 13, 2024
vanguard group inc
5.49%
2,153,790
SC 13G/A
Jan 26, 2024
blackrock inc.
7.4%
2,912,025
SC 13G/A
Sep 19, 2023
cas investment partners, llc
14.4%
5,416,116
SC 13D/A
Jun 23, 2023
cas investment partners, llc
16.0%
5,416,116
SC 13D
Feb 15, 2023
683 capital management, llc
5.7%
1,883,020
SC 13G/A
Feb 14, 2023
cas investment partners, llc
16.3%
5,416,116
SC 13G/A

Recent SEC filings of Cardlytics Inc

View All Filings
Date Filed Form Type Document
Jul 02, 2024
144
Notice of Insider Sale Intent
Jul 02, 2024
144
Notice of Insider Sale Intent
Jul 02, 2024
144
Notice of Insider Sale Intent
Jul 02, 2024
4
Insider Trading
Jul 02, 2024
4
Insider Trading
Jul 02, 2024
4
Insider Trading
Jul 02, 2024
4
Insider Trading
Jul 02, 2024
SC 13D/A
13D - Major Acquisition
Jun 04, 2024
144
Notice of Insider Sale Intent
Jun 04, 2024
4
Insider Trading

Peers (Alternatives to Cardlytics Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
17.9B
15.1B
1.59% -6.55%
12.4
1.18
5.28% 4.05%
11.4B
10.9B
2.10% -26.13%
10.53
1.05
-0.15% 19.70%
MID-CAP
2.4B
3.2B
15.71% 45.06%
27.99
0.75
7.78% 135.65%
2.3B
1.4B
-7.48% -32.09%
39.1
1.7
-0.85% 89.15%
2.2B
2.0B
10.37% 15.84%
30.77
1.15
0.16% 410.05%
SMALL-CAP
433.7M
312.5M
7.89% -10.29%
-2.51
1.39
5.95% 64.39%
16.9M
48.5M
-12.75% -55.05%
-0.78
0.35
17.58% -260.67%
5.7M
30.6M
-4.82% -41.04%
-1.05
0.19
16.58% 42.72%

Cardlytics Inc News

Latest updates
Simply Wall St18 hours ago
MarketBeat14 Jul 202406:37 pm
American Banking and Market News14 Jul 202409:15 am

Cardlytics Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-24.2%67,608,00089,167,00079,005,00076,701,00064,331,00082,503,00072,706,00075,405,00067,928,00090,049,00064,984,00058,853,00053,230,00067,082,00046,079,00028,222,00045,509,00069,293,00056,419,00048,730,00035,988,000
Costs and Expenses-52.9%90,434,000192,089,00099,657,000101,024,00052,104,000465,138,00061,186,000197,724,00032,272,000106,458,000104,777,000103,081,00075,399,00073,199,00062,218,00047,960,00057,438,00068,037,00063,017,00054,212,00042,489,000
  S&GA Expenses0.0%14,118,00014,111,00014,161,00015,205,00013,948,00016,825,00018,289,00021,983,00017,648,00018,998,00016,733,00017,063,00013,202,00012,502,00011,432,00010,405,00010,968,00012,370,00011,074,00011,047,0009,337,000
  R&D Expenses4.3%13,048,00012,511,00012,430,00014,847,00011,564,00014,801,00013,762,00013,581,00012,291,00011,811,00011,141,0008,934,0006,218,0005,088,0004,627,0003,966,0003,851,0002,958,0003,018,0002,782,0002,941,000
EBITDA Margin-33.9%-0.48-0.36-1.28-1.19-1.54-1.45-0.24-0.43-0.19-0.45-0.47-0.39---------
Interest Expenses2.4%-819,000-839,000-915,000-574,000-8,000-150,000-580,000-879,000-947,000-3,247,000-3,193,000-3,078,000-3,045,000-3,039,000-283,000-10,000284,000312,000-218,000-338,000-304,000
Income Taxes---------1,446,000--7,864,000-----------
Earnings Before Taxes75.9%-24,275,000-100,836,000-23,966,000-23,508,00013,608,000-378,279,0006,267,000-127,736,00033,038,000-19,699,000-44,529,000-47,306,000-24,895,000-6,777,000-15,356,000-19,758,000-13,531,0003,427,000-7,747,000-6,510,000-6,314,000
EBT Margin-26.8%-0.55-0.44-1.36-1.29-1.65-1.56-0.35-0.53-0.28-0.51-0.51-0.42---------
Net Income75.9%-24,275,000-100,836,000-23,966,000-23,508,00013,608,000-378,279,0006,267,000-126,290,00033,038,000-11,835,000-44,529,000-47,306,000-24,895,000-6,777,000-15,356,000-19,758,000-13,531,0003,427,000-7,747,000-6,510,000-6,314,000
Net Income Margin-26.8%-0.55-0.44-1.36-1.29-1.64-1.56-0.32-0.50-0.25-0.48-0.51-0.42---------
Free Cashflow-786.8%-18,268,0002,660,0001,143,0005,769,000-10,424,000-13,182,000-14,635,000-7,170,000-20,088,000-1,518,000-10,813,000-15,391,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-0.9%5695746356336856911,0661,0901,2311,2641,2251,2331,023423389183206224193144146
  Current Assets-2.5%218224206202246250249264319359336338703386354146170196166115117
    Cash Equivalents6.5%98.0092.0090.0092.0013912213915720823323725161429328898.0010210595.0032.0036.00
  Net PPE-12.5%3.003.003.003.005.006.007.009.0010.0011.0012.0013.0014.0014.0013.0013.0013.0014.0012.0012.0011.00
  Goodwill0%277277353353353353666666748743719718203--------
Liabilities-15.8%37043941039745248048652552057353651827826523953.0068.0081.00---
  Current Liabilities-40.1%10317117916819124925529424732727426392.0081.0058.0042.0058.0078.0063.0057.0050.00
  Short Term Borrowings---30.0030.00-----------------
  Long Term Debt0.2%228228---226---184---174--0.000.000.0037.0047.00
    LT Debt, Current-----------0.000.000.000.000.000.000.000.000.000.000.00
    LT Debt, Non Current-100.0%-228---226---184---174--0.000.000.0037.0047.00
Shareholder's Equity47.7%19913522523623221258156471269168971474515715013013814312747.0047.00
  Retained Earnings-2.2%-1,135-1,111-1,010-986-962-976-598-604-478-522-510-466-418-394-387-371-352-338-342-334-327
  Additional Paid-In Capital7.1%1,3321,2441,2301,2201,1911,1831,1691,1631,1881,2131,1991,1811,164551536500488481467379373
Shares Outstanding0%40.0040.0038.0035.0034.0033.0033.0034.0034.0032.0033.0033.00---------
Float----233---713---4,100-------1,800-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-700.4%-17,6172,9341,1945,751-10,064-13,101-14,434-6,678-19,691-555-10,458-14,978-12,5325,616-5,570-4,238-3,4064,10010,326-1,486-1,483
  Share Based Compensation-0.4%10,98511,02410,24911,7397,96812,4925,76712,84213,58512,84916,83013,3377,2487,58511,5789,1084,1253,5857,4863,0721,708
Cashflow From Investing-247.3%-4,747-1,367-3,146-2,747-2,802-3,153-3,304-4,269-5,034-3,414-2,871-348,448-151,962-3,857-2,873-1,950-1,437-4,609-1,248-3,182-1,981
Cashflow From Financing58902.1%28,32148.0021.00-50,07629,981-179-6.00-39,984182225370738484,6653,417197,6022,2723,1399,13043,939-9,052162
  Buy Backs--------40,000173-12.00904---------
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

CDLX Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Revenue$ 67,608$ 64,331
Costs and expenses:  
Partner Share and other third-party costs30,54333,384
Delivery costs6,1736,424
Sales and marketing expense14,11813,948
Research and development expense13,04811,564
General and administration expense14,48513,070
Acquisition, integration and divestiture costs01,723
Change in contingent consideration5,817(34,584)
Depreciation and amortization expense6,2506,575
Total costs and expenses90,43452,104
Operating (Loss) Income(22,826)12,227
Other expense (income):  
Interest expense, net(819)(8)
Foreign currency (loss) gain(630)1,389
Total other (expense) income(1,449)1,381
Income (loss) before income taxes(24,275)13,608
Net Income (Loss) Attributable to Parent, Total$ (24,275)$ 13,608
Net loss per share attributable to common stockholders, basic (in USD per share)$ (0.56)$ 0.41
Net loss per share attributable to common stockholders, diluted (in USD per share)$ (0.56)$ 0.40
Weighted-average common shares outstanding, basic (in shares)43,248,00033,595,000
Weighted-average common shares outstanding, diluted (in shares)43,248,00036,727,000

CDLX Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 97,766$ 91,830
Accounts receivable and contract assets, net105,164120,622
Other receivables5,8345,379
Prepaid expenses and other assets9,4916,097
Total current assets218,255223,928
Long-term assets:  
Property and equipment, net2,9063,323
Right-of-use assets under operating leases, net8,3427,310
Intangible assets, net32,21835,003
Goodwill277,202277,202
Capitalized software development costs, net27,00524,643
Other long-term assets, net3,0232,735
Total assets568,951574,144
Current liabilities:  
Accounts payable3,9744,425
Accrued liabilities:  
Accrued compensation8,09111,662
Accrued expenses4,3179,587
Partner Share liability35,53648,867
Consumer Incentive liability43,96452,678
Deferred revenue1,9942,405
Current operating lease liabilities2,0792,127
Current contingent consideration2,59539,398
Total current liabilities102,550171,149
Long-term liabilities:  
Convertible senior notes, net227,870227,504
Long-term operating lease liabilities7,6526,391
Long-term deferred revenue5167
Long-term debt30,02430,073
Long-term contingent consideration1,6674,162
Total liabilities369,814439,346
Stockholders’ equity:  
Common stock, $0.0001 par value—100,000 shares authorized, 48,174 and 39,728 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively99
Additional paid-in capital1,331,6281,243,594
Accumulated Other Comprehensive Income (Loss), Net of Tax3,0472,467
Accumulated deficit(1,135,547)(1,111,272)
Total stockholders’ equity199,137134,798
Total liabilities and stockholders’ equity$ 568,951$ 574,144
CDLX
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.
 CEO
 WEBSITEcardlytics.com
 INDUSTRYAdvertising Agencies
 EMPLOYEES473

Cardlytics Inc Frequently Asked Questions


What is the ticker symbol for Cardlytics Inc? What does CDLX stand for in stocks?

CDLX is the stock ticker symbol of Cardlytics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cardlytics Inc (CDLX)?

As of Wed Jul 17 2024, market cap of Cardlytics Inc is 433.68 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CDLX stock?

You can check CDLX's fair value in chart for subscribers.

What is the fair value of CDLX stock?

You can check CDLX's fair value in chart for subscribers. The fair value of Cardlytics Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cardlytics Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CDLX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cardlytics Inc a good stock to buy?

The fair value guage provides a quick view whether CDLX is over valued or under valued. Whether Cardlytics Inc is cheap or expensive depends on the assumptions which impact Cardlytics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CDLX.

What is Cardlytics Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Jul 17 2024, CDLX's PE ratio (Price to Earnings) is -2.51 and Price to Sales (PS) ratio is 1.39. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CDLX PE ratio will change depending on the future growth rate expectations of investors.